LUCID DIAGNOSTICS INC (LUCD) Stock Fundamental Analysis

NASDAQ:LUCD • US54948X1090

1.44 USD
-0.03 (-2.04%)
At close: Feb 27, 2026
1.44 USD
0 (0%)
After Hours: 2/27/2026, 8:16:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall LUCD gets a fundamental rating of 2 out of 10. We evaluated LUCD against 185 industry peers in the Health Care Equipment & Supplies industry. LUCD has a bad profitability rating. Also its financial health evaluation is rather negative. LUCD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • LUCD had negative earnings in the past year.
  • In the past year LUCD has reported a negative cash flow from operations.
  • In the past 5 years LUCD always reported negative net income.
  • LUCD had a negative operating cash flow in each of the past 5 years.
LUCD Yearly Net Income VS EBIT VS OCF VS FCFLUCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • The Return On Assets of LUCD (-123.77%) is worse than 84.32% of its industry peers.
  • LUCD has a Return On Equity of -254.86%. This is in the lower half of the industry: LUCD underperforms 75.14% of its industry peers.
Industry RankSector Rank
ROA -123.77%
ROE -254.86%
ROIC N/A
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUCD Yearly ROA, ROE, ROICLUCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for LUCD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LUCD Yearly Profit, Operating, Gross MarginsLUCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • LUCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LUCD has more shares outstanding
  • LUCD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LUCD has been reduced compared to a year ago.
LUCD Yearly Shares OutstandingLUCD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
LUCD Yearly Total Debt VS Total AssetsLUCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • LUCD has an Altman-Z score of -4.93. This is a bad value and indicates that LUCD is not financially healthy and even has some risk of bankruptcy.
  • LUCD has a worse Altman-Z score (-4.93) than 69.73% of its industry peers.
  • A Debt/Equity ratio of 0.86 indicates that LUCD is somewhat dependend on debt financing.
  • LUCD has a Debt to Equity ratio of 0.86. This is in the lower half of the industry: LUCD underperforms 74.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Altman-Z -4.93
ROIC/WACCN/A
WACC9.8%
LUCD Yearly LT Debt VS Equity VS FCFLUCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 1.90 indicates that LUCD should not have too much problems paying its short term obligations.
  • The Current ratio of LUCD (1.90) is worse than 63.78% of its industry peers.
  • LUCD has a Quick Ratio of 1.88. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.88, LUCD is in line with its industry, outperforming 50.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.88
LUCD Yearly Current Assets VS Current LiabilitesLUCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LUCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.12%, which is quite impressive.
  • The Revenue has been growing slightly by 5.01% in the past year.
  • The Revenue has been growing by 105.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%

3.2 Future

  • LUCD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.96% yearly.
  • The Revenue is expected to grow by 75.37% on average over the next years. This is a very strong growth
EPS Next Y34.33%
EPS Next 2Y29.31%
EPS Next 3Y21.51%
EPS Next 5Y11.96%
Revenue Next Year0.54%
Revenue Next 2Y60.26%
Revenue Next 3Y76.73%
Revenue Next 5Y75.37%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LUCD Yearly Revenue VS EstimatesLUCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
LUCD Yearly EPS VS EstimatesLUCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LUCD. In the last year negative earnings were reported.
  • Also next year LUCD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUCD Price Earnings VS Forward Price EarningsLUCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUCD Per share dataLUCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • LUCD's earnings are expected to grow with 21.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.31%
EPS Next 3Y21.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LUCD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LUCID DIAGNOSTICS INC

NASDAQ:LUCD (2/27/2026, 8:16:13 PM)

After market: 1.44 0 (0%)

1.44

-0.03 (-2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-23
Inst Owners27.81%
Inst Owner Change-10.29%
Ins Owners5.64%
Ins Owner Change0%
Market Cap188.52M
Revenue(TTM)4.40M
Net Income(TTM)-65.84M
Analysts83.33
Price Target3.87 (168.75%)
Short Float %8.28%
Short Ratio4.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.11%
Min EPS beat(2)11.04%
Max EPS beat(2)35.18%
EPS beat(4)3
Avg EPS beat(4)-42.23%
Min EPS beat(4)-222.25%
Max EPS beat(4)35.18%
EPS beat(8)4
Avg EPS beat(8)-28.03%
EPS beat(12)6
Avg EPS beat(12)-15.73%
EPS beat(16)7
Avg EPS beat(16)-15.95%
Revenue beat(2)0
Avg Revenue beat(2)-6.34%
Min Revenue beat(2)-12.5%
Max Revenue beat(2)-0.17%
Revenue beat(4)0
Avg Revenue beat(4)-16.73%
Min Revenue beat(4)-36.75%
Max Revenue beat(4)-0.17%
Revenue beat(8)1
Avg Revenue beat(8)-12.2%
Revenue beat(12)2
Avg Revenue beat(12)-11.77%
Revenue beat(16)2
Avg Revenue beat(16)-24.93%
PT rev (1m)0%
PT rev (3m)1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.92%
EPS NY rev (1m)0%
EPS NY rev (3m)3.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 42.86
P/FCF N/A
P/OCF N/A
P/B 7.3
P/tB 7.42
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.03
BVpS0.2
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -123.77%
ROE -254.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.76%
Cap/Sales 9.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.88
Altman-Z -4.93
F-Score4
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)37.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)87.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y34.33%
EPS Next 2Y29.31%
EPS Next 3Y21.51%
EPS Next 5Y11.96%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%
Revenue Next Year0.54%
Revenue Next 2Y60.26%
Revenue Next 3Y76.73%
Revenue Next 5Y75.37%
EBIT growth 1Y-6.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.07%
EBIT Next 3Y6.31%
EBIT Next 5Y4.51%
FCF growth 1Y-61.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.54%
OCF growth 3YN/A
OCF growth 5YN/A

LUCID DIAGNOSTICS INC / LUCD FAQ

What is the fundamental rating for LUCD stock?

ChartMill assigns a fundamental rating of 2 / 10 to LUCD.


Can you provide the valuation status for LUCID DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to LUCID DIAGNOSTICS INC (LUCD). This can be considered as Overvalued.


What is the profitability of LUCD stock?

LUCID DIAGNOSTICS INC (LUCD) has a profitability rating of 0 / 10.


What is the expected EPS growth for LUCID DIAGNOSTICS INC (LUCD) stock?

The Earnings per Share (EPS) of LUCID DIAGNOSTICS INC (LUCD) is expected to grow by 34.33% in the next year.